When is Childhood Cancer Awareness Month?
In 2012, President Obama proclaimed September as National Childhood Cancer Awareness Month to bring awareness to pediatric cancer, which remains the leading cause of death by disease for children under the age of 14.
See how we're treating and defeating childhood cancer, and show your support by going gold. A gold ribbon is the symbol for cancer affecting children.
Treatments invented at St. Jude have helped push the overall childhood cancer survival rate from 20% to more than 80% since we opened more than 50 years ago. And we won’t stop until no child dies from cancer. St. Jude creates more clinical trials for childhood cancer than any other children's hospital in the U.S.
Our global initiative with the World Health Organization aims to cure at least 60% of children with six of the most common cancers by 2030. To further advance cures, we freely share our research worldwide through data-sharing and analysis resources. Every child saved at St. Jude means thousands more are saved in your community and around the world.
St. Jude works to uncover these mutations and increase the chances of early detection and treatment. We are finding out why some cancers run in families and why certain people get more than one cancer.
More than 95% of childhood cancer survivors have significant treatment-related health issues.
About 420,000 adults in the U.S. are childhood cancer survivors. Our groundbreaking survivorship studies provide a greater understanding of the long-term effects of pediatric cancer treatment and help researchers develop novel therapies to minimize those late effects.
Learn more childhood cancer facts.
Learn about our patients, their diagnosis and how St. Jude is helping.
When they told us that everything will be free, it was like a thorn was taken away. We didn’t expect anything like this. We were so grateful.
Mark, Aspen's dad
- Neuroblastoma is a very rare type of cancerous tumor that almost always affects children.
- It can be inherited (passed down in families).
- Treatment can include surgery, chemotherapy and radiation therapy to kill cancer cells or stop them from growing.
- One clinical trial (a research to test new treatments) for neuroblastoma is currently being run by St. Jude scientists and doctors.
Every experience at St. Jude, you feel loved. St. Jude has given us hope, love, and a home away from home.
Abraham's mom, Andrea
- Medulloblastoma is the most common malignant brain tumor of childhood.
- It is a brain tumor of the cerebellum, which controls balance and coordinated movements.
- It's commonly treated with surgery to remove the tumor followed by radiation and chemotherapy.
- St. Jude has a clinical trial involving molecular-based therapy for brain tumors, including medulloblastoma.
I can't imagine what life after treatment would be like if we were worrying about bills.
Eleanor's dad, Daniel
Acute myeloid leukemia (AML)
- In acute myeloid leukemia (AML), white blood cells are abnormal and do not become healthy cells.
- Chemotherapy (“chemo”) is the primary AML treatment.
- St. Jude pioneered outpatient clinical trials for children with leukemia, reducing the need for inpatient stays.
- Read our clinical trial evaluating a new treatment for treatment of acute myelogenous leukemia.
Being at St. Jude as a patient made me want to come back and work there. I wanted to be a part of that incredibly hopeful environment.
Hayley, survivor of osteosarcoma
- Osteosarcoma is the most common type of bone cancer in children and teens.
- This cancer arises most often in the wide ends of long bones.
- Treatment includes surgery and chemotherapy.
- St. Jude surgeons continue to explore new limb-sparing techniques to improve survival and help children live normal lives after treatment.
Make a donation to help end childhood cancer.
We freely share our discoveries, so every child saved at St. Jude means doctors and scientists worldwide can use that knowledge to save thousands more children.
NATIONAL CHILDHOOD CANCER AWARENESS MONTH, 2012, BY THE PRESIDENT OF THE UNITED STATES OF AMERICA
While much remains to be done, our Nation has come far in the fight to understand, treat, and control childhood cancer. Thanks to ongoing advances in research and treatment, the 5 year survival rate for all childhood cancers has climbed from less than 50 percent to 80 percent over the past several decades. Researchers around the world continue to pioneer new therapies and explore the root causes of the disease, driving progress that could reveal cures or improved outcomes for patients. But despite the gains we have made, help still does not come soon enough for many of our sons and daughters, and too many families suffer pain and devastating loss.
My Administration will continue to support families battling pediatric cancer and work to ease the burdens they face. Under the Affordable Care Act, insurance companies can no longer deny health coverage to children because of pre existing conditions, including cancer, nor can they drop coverage because a child is diagnosed with cancer. The law also bans insurers from placing a lifetime dollar limit on the amount of coverage they provide, giving families peace of mind that their coverage will be there when they need it most. And as we work to ensure all Americans have access to affordable health care, my Administration will continue to invest in the cutting edge cancer research that paves the way for tomorrow's breakthroughs.
This month, we pay tribute to the families, friends, professionals, and communities who lend their strength to children fighting pediatric cancer. May their courage and commitment continue to move us toward new cures, healthier outcomes, and a brighter future for America's youth.
NOW, THEREFORE, I, BARACK OBAMA, President of the United States of America, by virtue of the authority vested in me by the Constitution and the laws of the United States, do hereby proclaim September 2012 as National Childhood Cancer Awareness Month. I encourage all Americans to join me in reaffirming our commitment to fighting childhood cancer.